On September 28, 2026, Sahir Ali, Founder and General Partner of Modi Ventures, was an invited speaker at the CEO Roundtable on Cancer (CEORT) 2026 Annual Meeting in Washington, D.C., a gathering of leaders across science, healthcare, finance, industry, and government.
Sahir joined Greg Simon for a session titled Capital, Risk, and the Oncology Innovation Gap, where he presented Modi Ventures’ BioStack framework for deploying capital across the AI-biomedical ecosystem, from foundation models to therapeutic translation.
The two-day meeting featured prominent leaders in cancer research and healthcare, including Dr. Anthony Letai, Director of the National Cancer Institute (NCI), and Dr. Peter Pisters, President of MD Anderson Cancer Center, alongside executives and leaders from Amgen, AstraZeneca, Merck, the FDA, and the Milken Institute.